Cite
Kim Y, Ereifej ES, Schwartzman WE, et al. Investigation of the Feasibility of Ventricular Delivery of Resveratrol to the Microelectrode Tissue Interface. Micromachines (Basel). 2021;12(12)doi: 10.3390/mi12121446.
Kim, Y., Ereifej, E. S., Schwartzman, W. E., Meade, S. M., Chen, K., Rayyan, J., Feng, H., Aluri, V., Mueller, N. N., Bhambra, R., Bhambra, S., Taylor, D. M., & Capadona, J. R. (2021). Investigation of the Feasibility of Ventricular Delivery of Resveratrol to the Microelectrode Tissue Interface. Micromachines, 12(12), . https://doi.org/10.3390/mi12121446
Kim, Youjoung, et al. "Investigation of the Feasibility of Ventricular Delivery of Resveratrol to the Microelectrode Tissue Interface." Micromachines vol. 12,12 (2021). doi: https://doi.org/10.3390/mi12121446
Kim Y, Ereifej ES, Schwartzman WE, Meade SM, Chen K, Rayyan J, Feng H, Aluri V, Mueller NN, Bhambra R, Bhambra S, Taylor DM, Capadona JR. Investigation of the Feasibility of Ventricular Delivery of Resveratrol to the Microelectrode Tissue Interface. Micromachines (Basel). 2021 Nov 25;12(12). doi: 10.3390/mi12121446. PMID: 34945296; PMCID: PMC8708660.
Copy
Download .nbib